Quality and Integrity of Data in Research, Development, and Innovation: A Risk Analysis Method Applied to Laboratory Notebooks in a University Pilot Plant

References

1. 1.↵
   1. Ahmed R.,
   2. Baseman H.,
   3. Ferreira J.,
   4. Genova T.,
   5. Harclerode W.,
   6. Hartman J.,
   7. Kim S.,
   8. Londeree N.,
   9. Long M.,
   10. Miele W.,
   11. Ramjit T.,
   12. Raschiatore,
   13. Tomonto C.

   PDA's Risk Management Task Force. PDA survey of quality risk management practices in the pharmaceutical, devices, & biotechnology industries. PDA J. Pharm. Sci. Technol. 2008, 62 (1), 1–21.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Hartford C. G.,
   2. Petchel K. S.,
   3. Mickail H.,
   4. Perez-Gutthann S.,
   5. McHale M.,
   6. Grana J. M.,
   7. Marquez P.

   Pharmacovigilance during the pre-approval phases: An evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines. Drug Safety 2006, 29 (8), 657–673.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Linna A.,
   2. Korhonen M.,
   3. Mannermaa J.,
   4. Airaksinen M.,
   5. Juppo A. M.

   Developing a tool for the preparation of GMP audit of pharmaceutical contract manufacturer. European Journal of Pharmaceutics and Biopharmaceutics 2008, 69 (2), 786–792.

   OpenUrlPubMed
4. 4.↵
   1. Santini C.

   Responsibility of the pharmaceutical industry in health safety. Ann. Pharm. Fr. 1999, 57 (1), 10–15.

   OpenUrlPubMed
5. 5.↵
   1. Botet J.,
   2. Fàbrega J.

   Gestion de la qualité en R+D+I. STP Pharma Prat. 2004, 14 (4), 359–371.

   OpenUrl
6. 6.↵
   1. Piton A.

   Risk-based assessment applied to QA GLP audits. How to fulfill regulatory requirements while making the best use of our common sense, knowledge, talents, and resources? Ann. Ist. Super. Sanita 2008, 44 (4), 379–384.

   OpenUrlPubMed
7. 7.↵
   1. Vesper J. L.

   Risk Assessment and Risk Management in the Pharmaceutical Industry: Clear and Simple; Parental Drug Association: Bethesda, MD; Davis Healthcare International Publishing: River Grove, IL, 2006.
8. 8.↵
   1. Sykes I. K.

   How is ICH Q9 implemented in the industry?STP Pharma Prat. 2008, 18 (5), 475–483.

   OpenUrl
9. 9.↵
   International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Quality Risk Management, 2005.
10. 10.↵
    1. Lipovetsky S.

    Pareto 80/20 law: derivation via random partitioning International Journal of Mathematical Education in Science and Technology 2009, 40 (2), 271–277.

    OpenUrl